Switch from calcineurin inhibitors to belatacept in kidney transplant patients with chronic-active antibody mediated rejection results in lower decline in kidney function at three years

J Nephrol. 2021 Jun 28. doi: 10.1007/s40620-021-01099-7. Online ahead of print.NO ABSTRACTPMID:34181198 | DOI:10.1007/s40620-021-01099-7

Source: Journal of Nephrology - June 28, 2021 Category: Urology & Nephrology Authors: Tristan de Nattes Arnaud Fran çois Sophie Candon Isabelle Etienne Charlotte Laurent Marie Matignon Antoine Morel Johan Noble Martin Planchais Dominique Guerrot Dominique Bertrand Source Type: research